AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing
Investor's Business DailyAbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance.
The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's…